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Receptors for neurotransmitters require scaffolding pro-
teins for membrane microdomain targeting and for regulat-
ing receptor function. Using a yeast two-hybrid screen, -ac-
tinin-1, a major F-actin cross-linking protein, was identified
as a binding partner for the C-terminal domain of metabo-
tropic glutamate receptor type 5b (mGlu5b receptor). Co-ex-
pression, co-immunoprecipitation, and pull-down experi-
ments showed a close and specific interaction between
mGlu5b receptor and -actinin-1 in both transfected HEK-
293 cells and rat striatum. The interaction of-actinin-1 with
mGlu5b receptor modulated the cell surface expression of the
receptor. This was dependent on the binding of-actinin-1 to
the actin cytoskeleton. In addition, the -actinin-1/mGlu5b
receptor interaction regulated receptor-mediated activation
of the mitogen-activated protein kinase pathway. Together,
these findings indicate that there is an -actinin-1-depend-
ent mGlu5b receptor association with the actin cytoskeleton
modulating receptor cell surface expression and functioning.
Glutamate and aspartate are the major excitatory neuro-
transmitters in the mammalian central nervous system (1, 2).
These excitatory amino acids act on glutamate receptors and
play an important role in many physiological functions,
including learning, memory, and development (3). Glutamate
receptors are widely distributed in the central nervous system
and include three subtypes of ionotropic glutamate receptors
(-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid,
NMDA,3 and kainate receptors) and a family of G protein-cou-
pled metabotropic glutamate (mGlu) receptors that act
through different second messenger pathways. Eight members
of the mGlu receptor family have been identified and catego-
rized into three subgroups on the basis of their sequence
homology, agonist selectivity and signal transduction pathway.
Group I contains the mGlu1 and mGlu5 receptor subtypes,
which are coupled to phospholipase C in transfected cells and
have quisqualic acid as their most potent agonist (4). The
mGlu5 receptor is expressed in two splice variants, mGlu5a and
mGlu5b, which differ in that mGlu5b has a 33-amino acid insert
in the intracellular C-terminal domain. Interestingly, both sub-
types of mGlu5 are heavily expressed in striatum with the con-
sideration that mGlu5b might be considered as an “adult” vari-
ant and mGlu5a is more a “neonatal” variant (5).
The actin-based cytoskeleton is connected to the plasma
membrane via a lattice-like network of actin-binding proteins
that form the membrane skeleton or membrane-associated
cytoskeleton (6). Themajor structural component of the mem-
brane skeleton is spectrin (also referred to as fodrin in non-
erythroid cells), a flexible rod-shaped molecule composed of
homologous, but non-identical- and-subunits. Other actin-
binding proteins, like filamin A and -actinin, also participate
in the maintenance of this membrane-associated cytoskeleton
and are essential for the anchoring of transmembrane proteins.
major F-actin cross-linking protein (7), present in both mus-
cle and non-muscle cells, is -actinin. There are four -actinin
genes, two non-skeletal muscle isoforms, -actinin-1 and -4,
and two skeletal muscle isoforms, -actinin-2 and -3 (8). All of
them share a general structure, which can be divided into three
functionally distinct domains: the N terminus containing two
calponin homology domains that bind to actin filaments (9), a
central region composed of four spectrin-like motifs (10),
which acts as a switchboard for interactions with multiple pro-
teins, and the C terminus, which contains EF-hand domains
responsible for Ca2 binding (11) and terminates in a PDZ
domain-binding sequence, ESDL (12) (for review see Refs. 13
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and 14). Members of the -actinin family, namely -actinin-1,
-2, and -4, are abundantly represented in postsynaptic density
(PSD) excitatory synapses (15, 16), where it is believed they
regulate postsynaptic actin dynamics and spine morphology
(17). Recently, the spatial expression of -actinin-2 in the rat
central nervous system has been analyzed. The highest levels of
the protein are found in the striatum, cortex, and hippocampus,
where -actinin-2 interacts with both the NMDA subtype of
glutamate receptor (18, 19) and the adenosine A2A receptor
(20). Also, -actinin-1 showed a high expression level in neu-
rons of striatum, whereas the cerebellum and other subcortical
structures showed only weak labeling (21).
In the present studywe carried out aGAL-4-based yeast two-
hybrid screen to identify mGlu5b partners in adult brain. Using
a C-terminal tail region of the receptor as bait we identified
-actinin-1 and -4 as novel binding partners of the mGlu5b
receptor. We focus on the characterization of -actinin-1-
mGlu5b interaction, because both proteins are heavily
expressed in the same adult brain area, the striatum. This inter-
action might have relevant physiological consequences,
because we demonstrate, in the present work, that -actinin-1
controls the cell surface expression and functioning of mGlu5b
receptor.
EXPERIMENTAL PROCEDURES
Plasmid Constructs—Two EcoRI-XhoI fragments of the
C-terminal tail of the mGlu5b receptor were subcloned into the
bait vector pHybLexA/Zeo (Invitrogen). One fragment coding
for amino acids 828–1006 (LmGlu5b) was amplified using
TaqDNA polymerase (Sigma) and the following primers:
FLmGlu5b (5-GGCTGGAATTCAAACCGGAGAGAAATG-
TGCG-3) and RLmGlu5b (5-GCCTCGAGTCACAGCGAC-
GGCGCATC-3). For the second fragment coding for amino
acids 828–932 (SmGlu5b) the following primers were used:
RLmGlu5b (5-AGACTCGAGGTCACAAATGTTGCCCC-
CGG-3) and the same FLmGlu5b.
Human -actinin-1 cloned in the HindIII restriction site of
pEYFP-N1 (Clontech) was kindly provided by Dr. Carol Otey,
Dept. of Cell and Molecular Physiology, University of North
Carolina, Chapel Hill. Several human -actinin-1-GST fusion
proteins were made by PCR amplification and cloning into the
EcoRI/XhoI sites of pGEX-4T-1 (AmershamBiosciences) using
the following primers: RFA1 (5-CCGCTCGAGTTAGAGGT-
CACTCTCGCCGTACAGC-3) and FFA1 (5-CCGGAATT-
CATGGACCATTATGATTCTCAG-3) for the fusion protein
GST--actinin-1, RFA1 and FF1A1 (5-CCGGAATTCACGG-
AGGAGCATGCCCGACAGCAGC-3) for the fusion protein
GST--actinin-1-(619–892), RFA1 and FF2A1 (5-CCGGAA-
TTCAATGAGTTCCGGGCCTCCTTCAACC-3) for the
fusion protein GST--actinin-1-(746–892), RFA1 and FF3A1
(5-CCGGAATTCCGAGACAGCCGACACAGATACAGC-
3) for the fusion protein GST--actinin-1-(816–892), and
FFA1 and RF4A1 (5-CCGCTCGAGTCACGGGACATGAA-
GTCAATGAAGGCC-3) for the fusion protein GST--
actinin-1-(1–816). To perform FRET experiments the mGlu5b
receptor was subcloned into the EcoRI/BamHI sites of
pGFP2-N3 vector (PerkinElmer Life Sciences) using the prim-
ers Fm5 (5-CCCGTTGAATTCCTTTCCTAAAATG-3) and
Rm5 (5-CCGCCAGGATCCCGCAACGATGAAGAACT-3)
to generate the construct mGlu5b-GFP2. Also, four human
-actinin-1-YFP fusion proteins were made by PCR amplifica-
tion and cloning into the HindIII sites of pEYFP-N1 (Clontech)
using the following primers: Rmut (5-CTGCAGAATTC-
GAAGCTTGAGGTC-3) and Fmut1 (5-CCCAAGCTTATG-
GAGATCCGGAGGCTGGAGCG-3) for the fusion protein
-actinin-1-(358–892)-YFP, Rmut and Fmut2 (5-CCCAAG-
CTTATGAACGAGTTCCGGGCCTCCTTCAA-3) for the
fusion protein -actinin-1-(746–892)-YFP and Rmut and Fmut3
(5-CCCAAGCTTATGTCCCGCGAGACAGCCGACACAG-
3) for the fusion protein -actinin-1-(816–892)-YFP, Fmut4
(5-CCCAAGCTTATGGACCATTATGATTCTCAGC-3) and
Rmut4 (5-CCCAAGCTTGTCAATGAAGGCCTGGAAT-
GTC-3) for the fusion protein -actinin-1-(1–815)-YFP.
Yeast Two-hybrid System—Yeast two-hybrid screening was
performed as described previously (20). Briefly, a bait strainwas
created by transforming pHybLex-LmGlu5b into Saccharomy-
ces cerevisiae strain L40 as described in the manufacturer’s
instructions (Hybrid Hunter, Invitrogen). The bait strain was
co-transformed with an adult mouse brain cDNA library con-
structed in the Gal4-activating domain vector pPC86 (Invitro-
gen), and transformants were plated onto minimal yeast media
lacking histidine, tryptophan, uracil, and lysine, containing 300
mg/ml Zeocin (Invitrogen) and 5 mM 3-aminotriazole. Plates
were incubated at 30 °C for 5 days, and yeast colonies that grew
on histidine-deficient media were re-streaked onto fresh selec-
tive plates and assayed for -galactosidase activity as per the
manufacturer’s instructions. Prey plasmids were isolated from
yeast and electroporated into Escherichia coli XL-1Blue elec-
trocompetent cells (Stratagene). The 5-end of each clone was
sequenced using a vector primer. To confirm the interaction in
yeast, purified prey plasmids were re-transformed with the
pHybLex-LmGlu5b and pHybLex-SmGlu5b baits and with the
bait empty bait vector pHybLex/Zeo and tested for growth on
selective plates and -galactosidase activity.
For liquid -galactosidase assays 1.5 ml of each culture,
grown for 48 h at 30 °C, was spun, and the pellet was re-sus-
pended in 200 l of Z buffer (60 mM Na2HPO4, 40 mM
NaH2PO4, 10 mM KCl, 1 mM MgSO4, pH 7.0). A small amount
of glass beads (425–600 m, Sigma) was added, and the mix-
ture was sonicated for 5–10 min. After cell lysis, the samples
were spun to pellet the cell debris. 100 l of supernatant was
transferred to a new microcentrifuge tube, and 700 l of Z
buffer containing -mercaptoethanol (27 l/10 ml) was added.
150 l of 2.5 mg/ml ortho-nitrophenyl--galactoside (Sigma)
was added to the sample, and the mixture was incubated at
37 °C for 3 h. The absorbance was read at 420 nm and referred
to the amount of protein present in each sample. For strong
enzymatic reactions (i.e. when the color started to appear after
a few minutes of incubation), a 1:10 dilution of the yeast lysate
was used and the absorbance at 420 nm was multiplied by 10.
Antibodies—The primary antibodies were: rabbit anti-
mGlu5a/b receptor polyclonal antibody (Upstate), rabbit anti--
actinin polyclonal antibody (Santa Cruz Biotechnology, Santa
Cruz, CA),mouse anti--actininmonoclonal antibody (Sigma),
mouse anti-NR1 monoclonal antibody (Upstate), rabbit anti-
GST polyclonal antibody (22), mouse anti-GFP monoclonal
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antibody (Sigma), rabbit anti-extracellular signal-regulated
kinase (ERK) 1/2 polyclonal antibody (clone M-5670, Sigma),
mouse anti-phosphorylated ERK1/2 (clone M-8159, Sigma),
and mouse anti-calnexin monoclonal antibody (BD Trans-
duction Laboratories). The secondary antibodies were:
horseradish-peroxidase (HRP)-conjugated goat anti-rabbit
IgG (Pierce), HRP-conjugated anti-rabbit IgG TrueBlotTM
(eBioscience), HRP-conjugated rabbit anti-mouse IgG
(Dako), Texas red-conjugated goat anti-rabbit IgG (Molec-
ular Probes), and AlexaFluor488-conjugated goat anti-
mouse IgG (Molecular Probes).
Cell Culture, Transfection, and Membrane Preparation—
HEK-293 cells were grown in Dulbecco’s modified Eagle’s
medium (Sigma) supplemented with 1 mM sodium pyruvate, 2
mM L-glutamine, 100 units/ml penicillin/streptomycin, and
10% (v/v) fetal bovine serum at 37 °C and in an atmosphere of
5% CO2. HEK-293 cells growing in 25-cm3 dishes or 20-mm
coverslips were transiently transfected with 10 g of DNA
encoding for the proteins specified in each case by calcium
phosphate precipitation (23). The cells were harvested at either
24 or 48 h after transfection.
Neuronal striatal primary cultures were obtained as
described previously (24) and plated at a density of 5  104
cells/cm2. Membrane suspensions from rat striatum or from
transfected HEK cells were obtained as described previously
(25, 26).
Gel Electrophoresis and Immunoblotting—SDS-PAGE was
performed using 7.5 or 10% polyacrylamide gels. Proteins were
transferred to polyvinylidene difluoride membranes using a
semi-dry transfer system and immunoblotted with the indi-
cated antibody and then HRP-conjugated goat anti-rabbit IgG
(1/60,000), HRP-conjugated rabbit anti-goat IgG (1/60,000), or
HRP-conjugated anti-rabbit IgG TrueBlotTM (1/1,000). The
immunoreactive bands were developed using a chemilumines-
cent detection kit (Pierce) (27).
Expression of GST Fusion Proteins and Pull-down Assays—
Recombinant fusion proteins GST, GST--actinin-1, GST-
-actinin-1-(1–816), GST--actinin-1-(619–892), GST--
actinin-1-(746–892), and GST--actinin-1-(816–892) were
expressed in the E. coli BL21 strain (Invitrogen) with 0.1 mM
isopropyl--D-thiogalactopyranoside (Sigma) for 3 h at
37 °C and purified on glutathione-Sepharose (Amersham
Biosciences) as described previously (22). 5 g of each fusion
protein was coupled to 100 l of a 50% suspension (v/v) of
glutathione-agarose beads (Sigma) in PBS for 1 h at 4 °C.Mem-
branes from HEK-293 transiently transfected with the mGlu5b
receptor were solubilized in ice-cold lysis buffer (PBS, pH 7.4,
containing 1% (v/v) Nonidet P-40) for 30 min at 4 °C. The sol-
ubilized material was centrifuged at 14,000 g for 20 min, and
the supernatant was pre-cleared with 100l of the 50% suspen-
sion (v/v) of glutathione-agarose beads for 1 h with constant
rotation at 4 °C. After the pre-clearing, supernatants were
transferred to a clean tube containing GST, GST--actinin-1,
GST--actinin-1-(1–816), GST--actinin-1-(619–892), GST-
-actinin-1-(746–892), or GST--actinin-1-(816–892) cou-
pled to the glutathione-agarose and incubated overnight with
constant rotation at 4 °C. Subsequently, the beads were washed
twice with ice-cold lysis buffer, twice with ice-cold lysis buffer
containing 0.1% (v/v) Nonidet P-40, and once with PBS and
aspirated to dryness with a 28-gauge needle. Subsequently, 30
l of SDS-PAGE sample buffer (8 M urea, 2% SDS, 100 mM
dithiothreitol, 375 mM Tris, pH 6.8) was added to each sample.
Immune complexes were dissociated by heating to 37 °C for 2 h
and resolved by SDS-PAGE in 7.5% gels and immunoblotted as
described above.
Immunoprecipitation and Immunocytochemistry—For im-
munoprecipitation, membranes from transiently transfected
HEK cells were solubilized in ice-cold lysis buffer (PBS, pH
7.4, containing 1% (v/v) Nonidet P-40) for 30 min on ice. In
the case of rat striatum membranes these were solubilized in
2% SDS in PBS and then diluted with 5 volumes of ice-cold
2% (v/v) Nonidet P-40 in PBS (28). In both cases, the solubi-
lized preparation was then centrifuged at 13,000  g for 30
min. The supernatant (1 mg/ml) was processed for immuno-
precipitation, each step of which was conducted with con-
stant rotation at 0–4 °C. The supernatant was incubated
overnight with the indicated antibody. Next 40l of a suspen-
sion of protein G cross-linked to agarose beads was added, and
the mixture was incubated overnight. The beads were washed
and treated as described above.
For immunocytochemistry, transiently transfectedHEK-293
cells, or rat neuronal striatal primary cultures, were fixed in 4%
paraformaldehyde for 15min, and washed with PBS containing
20mMglycine (buffer A) to quench the remaining free aldehyde
groups. Cells were permeabilizedwith buffer A containing 0.2%
Triton X-100 for 5min. Blocking was performed using buffer A
containing 1% bovine serum albumin (buffer B). Cells were
labeled for 1 h at room temperature with the indicated primary
antibody, washed for 30 min in buffer B, and stained with the
corresponding secondary antibodies for another hour. Samples
were rinsed and then examined using a confocal microscope
(29, 30). To test the specificity of the antibodies we omitted or
replaced the primary antibodieswith buffer B.Under these con-
ditions, no selective labeling was observed.
FRET Experiments Analyzed by Fluorometry—Forty-eight
hours after transfection, cells were rapidly washed twice in PBS,
detached, and re-suspended in the same buffer. To control the
number of cells, the protein concentration of the samples was
determined using a Bradford assay kit (Bio-Rad) using bovine
serumalbumin dilutions as standards. Cell suspension (20g of
protein) was distributed in duplicate into 96-well microplates
(black plates with a transparent bottom). Plates were read in a
Fluostar Optima Fluorometer equipped with a high energy
xenon flash lamp, using a 10 nm bandwidth excitation filter at
400 nm (393–403 nm), and 10 nm bandwidth emission filters
corresponding to a 506–515 nm filter (Ch 1) and a 527–536 nm
filter (Ch 2). Gain settings were identical for all experiments to
keep the relative contribution of the fluorophores to the detec-
tion channels constant for spectral un-mixing. Quantitation of
FRET was performed as described previously (31). The contri-
bution of each fluorophore to both detection channels was cal-
culated from the readings obtained by expressing each GFP
variant separately. The spectral signatures of the different
receptors fused to either GFP2 or YFP did not significantly vary
from the determined spectral signatures of the fluorescent pro-
teins alone. Linear un-mixingwas performed according toZim-
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mermann et al. (32) andwas used to determine the fluorescence
emitted by each of the fluorophores.
Biotinylation of Cell Surface Proteins—Cell surface proteins
were biotinylated as described previously (33, 34). Briefly, HEK-
293 cells transiently transfected with the mGlu5b receptor in
the absence, or presence, of -actinin-1-YFP constructs were
washed three times in borate buffer (10mMH3BO3, pH 8.8; 150
mM NaCl) and then incubated with 50 g/ml Sulfo-NHS-LC-
Biotin (Pierce) in borate buffer for 5 min at room temperature.
Cells were washed three times in borate buffer and again incu-
bated with 50 g/ml Sulfo-NHS-LC-Biotin in borate buffer for
10min at room temperature, and then 13mMNH4Clwas added
for 5 min to quench the remaining biotin. Cells were washed in
Tris-buffered saline, disruptedwith three 10-s strokes in a Poly-
tron, and centrifuged at 14,000  g for 30 min. The pellet was
solubilized in ice-cold lysis buffer (see above) for 30 min and
centrifuged at 14,000  g for 20 min. The supernatant was
incubated with 80 l of streptavidin-agarose beads (Sigma) for
1 h with constant rotation at 4 °C. The beads were washed and
treated as described above and processed for immunoblotting.
Extracellular Signal-regulated Kinase Assay—Before stimu-
lation with quisqualic acid transiently transfected HEK-293
cells were serum-starved for 16 h by replacing the usual culture
medium for normal Dulbecco’s modified Eagle’s mediumwith-
out glutamine and fetal bovine serum but containing 2 mM
sodium pyruvate and 1 unit/ml glutamate-pyruvate transami-
nase (Roche Applied Science) to eliminate glutamate from the
medium. After stimulation, cells were washed with ice-cold
PBS and scraped into 1 ml of lysis buffer containing 1% Tri-
ton X-100, 50 mM Tris-HCl, pH 7.6, 45 mM -glycerophos-
phate, 50 mM NaF, and 1 mM NaVO4 in the presence of a
protease inhibitor mixture (Sigma). Lysed cells were centri-
fuged for 20 min at 14,000 rpm at 4 °C, and equal protein
concentrations were resolved on 10% SDS-PAGE, blotted
onto Immobilon-P membrane, and incubated with rabbit
anti-ERK1/2 (1/40,000) or mouse anti-phospho-ERK1/2
(1/2,500). Quantitative analysis of detected bands was per-
formed by using densitometric scanning (35).
RESULTS
Yeast Two-hybrid Screening—To identify intracellular
proteins interacting with the mGlu5b receptor, a region con-
taining 178 amino acids of the C-terminal tail of the receptor
(amino acids 828–1006) were fused in-frame with LexA in
the pHybLexA/Zeo vector (LmGlu5b, Fig. 1A) and used to
screen a mouse brain cDNA library using the yeast two-hybrid
system. Of the seven clones, from the 1  106 total transfor-
FIGURE 1. -Actinin-1 interacts with mGlu5b receptor in the yeast two-
hybrid system. A, schematic representation of the pHybLex-LmGlu5b
(LmGlu5b) fusion protein containing amino acids 828–1006 and pHybLex-
SmGlu5b (SmGlu5b) fusion protein containing amino acids 828–932 of the
C-terminal tail mGlu5b receptor. Quantitation of the interaction of-actinin-1
isoform with mGlu5b receptor fusion proteins was determined using a liquid
-galactosidase assay as described under “Experimental Procedures” (inset
panel in A). Data are mean  S.E. values of three replicates. pHyb, pHybLex
(Invitrogen); TM7, seven transmembrane domains. B, schematic representa-
tion of the interacting region of -actinin-1. The interacting region of -acti-
nin-1 with the C-Terminal tail mGlu5b receptor comprises amino acids 369–
892 of -actinin-1. CH, calponin homology domain; SPEC, spectrin-like motif;
EFH, EF-hand domain. C, the regions containing transmembrane 7 (TM7) and
C-terminal tail of hmGlu5b (accession code: D28539) and hmGlu5a (accession
code: D28538) are aligned.Dashed lines indicate the regionof deletions in the
hmGlu5a (32 amino acids) receptor variant. The putative -actinin-1 binding
motif is underlined in black (amino acids 932–1006). The two boxed regions
represent the Ca2/calmodulin binding motifs. Also illustrated are motifs
required for Homer and PDZ domain interactions.
FIGURE 2.Mappingof themGlu5b receptor interaction site of-actinin-1.
On the left are shown the -actinin-1 GST fusion proteins used in the pull-
down experiments. Transiently expressed mGlu5b receptor in HEK-293 cells
extracts (Crude)waspulleddownwithGST--actinin-1 (lane1), GST--actinin-
1-(619–892) (lane 2), GST--actinin-1-(746–892) (lane 3), GST--actinin-1-
(816–892) (lane 4), GST alone (lane 5), and GST--actinin-1-(1–816) (lane 6).
mGlu5b receptor was detected using a polyclonal antibody against the
mGlu5a/b receptor (1/1,000), and the GST fusion proteins with a polyclonal
antibody were used against GST (1/2,000). The primary bound antibody was
detected using a HRP-conjugated goat anti-rabbit antibody (1/60,000). The
immunoreactive bands were visualized by chemiluminescence.
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mants screened that were found to grow onto nutritional-defi-
cient plates and activated the -galactosidase assay, three were
identified as different isoforms of the actin binding protein
-actinin, one clone for -actinin-1, and another two for -ac-
tinin-4. The isolated -actinin-1 clone comprises amino acids
369–892 that include part of the spectrin-like motif and the
Ca2 binding domain (Fig. 1B). To determine the region of the
C-terminal domain of themGlu5b receptor that interacted with
-actinin-1, another LexA fusion protein missing the last 74
amino acids of the former LmGlu5b was constructed (SmGlu5b,
Fig. 1A) and tested for its ability to bind -actinin-1. This
shorter fusion protein could not interact with -actinin-1 as
tested using a liquid-galactosidase assay (Fig. 1A, inset panel),
thus mapping the interacting domain to within amino acids
932–1006 of mGlu5b receptor. This region is common in both
mGlu5a and mGlu5b receptor isoforms and close to the
described Ca2/calmodulin binding motifs (36) (Fig. 1C).
-Actinin-1 Binds to the C-terminal Domain of mGlu5b
Receptor—By means of pull-down experiments we tested the
ability of naturally expressed full-length mGlu5b receptor to
associate withGST fusion proteins containing different regions
of -actinin-1 (Fig. 2, left part). As shown in Fig. 2, an immu-
noreactive band of 130 kDa corresponding to the mGlu5b
receptor could be detected in the crude extracts fromHEK-293
cells transiently expressing the receptor (Fig. 2, Crude). This
band was observed in pull-down assays when cell lysates were
incubatedwithGST--actinin-1,GST--actinin-1-(619–892),
GST--actinin-1-(746–892), and GST--actinin-1-(816–892)
(Fig. 2, lanes 1–4, respectively), but was not detected either
with GST--actinin-1-(1–816) fusion protein or with GST
alone (Fig. 2, lanes 6 and 5, respectively). This result shows that
the naturally expressed mGlu5b receptor binds specifically to a
region in the -actinin-1 protein located within amino acids
816 and 892. On the other hand, the binding of the mGlu5b
receptor to this region was not altered by the presence of 2 mM
Ca2 or 5mMEDTA (data not shown). Interestingly, this C-ter-
minal region of -actinin-1 (76 amino acids) displays 70%
amino acid sequence identity (84% similarity) across the -ac-
tinin-1, -2, and -3 isoforms (37) and contains a PDZ domain-
binding sequence, ESDL (11).
Interaction of themGlu5b Receptor and-Actinin-1 in Trans-
fected HEK-293 Cells and in Rat Striatum—The association of
the mGlu5b receptor and -actinin-1 was subsequently studied
in transfected HEK-293 cells by double immunolabeling exper-
iments and co-immunoprecipitation. By confocal microscopy
analysis of HEK-293 cells transiently co-transfected with the
cDNA encoding for the mGlu5b receptor and -actinin-1-YFP,
a marked overlap in the distribution of the two proteins was
found at the plasma membrane level (Fig. 3). Interestingly,
FIGURE3.Co-expressionofmGlu5b receptorand-actinin-1 constructs in
HEK-293 cells.HEK-293 cellswere transiently transfectedwithmGlu5b receptor
alone, -actinin-1-YFP alone, mGlu5b receptor plus -actinin-1-YFP, mGlu5b
receptor plus -actinin-1-(358–892)-YFP, mGlu5b receptor plus -actinin-1-
(746–892)-YFP, mGlu5b receptor plus -actinin-1-(816–892)-YFP, mGlu5b
receptor plus -actinin-1-(1–815)-YFP or mGlu5b receptor plus YFP. Cells
were processed for immunocytochemistry (see “Experimental Procedures”)
using a polyclonal antibody against mGlu5a/b receptor (1/200) followed by
Texas Red-conjugated goat anti-rabbit (1/2000). Cells were analyzed by dou-
ble immunofluorescence with a confocal microscope. Superimposition of
images (merge) reveal co-distribution of mGlu5b receptor with -actinin-1
constructs in yellow. Scale bar, 10 m.
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when the double immunolabeling experiment was performed
inHEK-293 cells transiently transfected with the cDNA encod-
ing the mGlu5b receptor and either -actinin-1-(358–892)-
YFP, a-actinin-1-(746–892)-YFP, or -actinin-1-(816–892)-
YFP some co-distribution was observed at the plasma
membrane, although most of the -actinin-1 constructs
showed a cytosolic and nuclear distribution. This latter distri-
butionmight arise, because all of the -actinin-1 constructs are
missing the calponin homology domain, which accounts for the
binding to actin filaments. On the other hand, a mutant of the
-actinin-1 lacking the last 76 amino acids, namely -actinin-
1-(1–815)-YFP, showed a low level of co-distribution with
mGlu5b besides this mutant was also expressed at the plasma
membrane (Fig. 3). These results suggest that the putative
mGlu5b-interacting domain of -actinin-1 is necessary to bring
together these two proteins. Finally, when the mGlu5b receptor
was co-transfected with YFP the co-distribution between these
two proteins was very low (Fig. 3), suggesting that the co-distri-
bution between the mGlu5b receptor, -actinin-1-YFP, and its
deleted constructs is indeed specific. When cell extracts of
HEK-293 cells transiently transfectedwith themGlu5b receptor
plus -actinin-1-YFP, -actinin-1-(358–892)-YFP, -actinin-
1-(746–892)-YFP, or-actinin-1-(816–892)-YFPwere immu-
noprecipitated with an antibody against GFP and these immu-
noprecipitates were analyzed by Western blot using an
antibody against the mGlu5a/b receptor, a band of 130 kDa,
which corresponds to the mGlu5b receptor, was observed (Fig.
4, bottom panel, lanes 1–4). Interestingly, this band did not
appear in immunoprecipitates from cells co-transfected
with mGlu5b receptor plus YFP (Fig. 4, bottom panel, lane 5)
or from cells co-transfected with mGlu5b receptor plus -ac-
tinin-1-(1–815)-YFP (Fig. 4, bottom panel, lane 6), suggest-
ing again that the region comprised between amino acids 816
and 892 of -actinin-1 is responsible for the interaction with
mGlu5b receptor.
The protein-protein interaction between the mGlu5b recep-
tor and -actinin-1 was determined by a FRET approach using
themGlu5b-GFP2 and -actinin-1-YFP pair (see “Experimental
Procedures”). FRET efficiencywas determined to be27% (Fig.
5). The relatively low FRET efficiency (33%) of a negative
control constituted by the pair mGlu5b-GFP2 and YFP is con-
sistent with a specific energy transfer between mGlu5b-GFP2
and -actinin-1-YFP (FRET efficiency61%) (Fig. 5). Further-
more the FRET efficiency between mGlu5b-GFP2 and either
-actinin-1-(358–892)-YFP, -actinin-1-(746–892)-YFP, or
-actinin-1-(816–892)-YFP was significantly higher than the
negative control (Fig. 5). This is consistent with the stretch of
-actinin-1 amino acid sequence (amino acids 816–892) form-
ing a direct interaction with themGlu5b receptor. Interestingly,
with the smaller -actinin-1 construct, -actinin-1-(816–
892)-YFP, a marked increase in FRET efficiency was observed
when comparedwith the other constructs, probably due it to its
higher expression, easier access, and therefore closer contact to
the receptor. Under the same experimental conditions, the
-actinin-1-(1–815)-YFP, the -actinin-1 mutant lacking the
last 76 amino-acids, showed a FRET efficiency similar to that
observed for the pair mGlu5b-GFP2 and YFP (negative control)
(Fig. 5). Together, these results demonstrate that -actinin-1
can interact withmGlu5b receptor in a heterologous system and
that the interaction is mediated by the last 76 amino acids
(amino acids 816–892).
To assess the physiological relevance of the -actinin-1/
mGlu5b receptor interaction, co-immunoprecipitation experi-
FIGURE 4. Co-immunoprecipitation of mGlu5b receptor and -actinin-1
constructs in HEK-293 cells.HEK-293 cells were transiently transfectedwith
mGlu5b receptor and -actinin-1-YFP (lane 1), -actinin-1-(358–892)-YFP
(lane 2), -actinin-1-(746–892)-YFP (lane 3), -actinin-1-(816–892)-YFP (lane
4), YFP alone (lane 5), and -actinin-1-(1–815)-YFP (lane 6). Cells were pro-
cessed for immunoprecipitation (see “Experimental Procedures”) using a
monoclonal anti-GFP antibody (2 g/ml). The crude extracts (Crude) and
immunoprecipitates (IP: anti-GFP) were analyzed by SDS-PAGE and immuno-
blottedusing apolyclonal antibody againstmGlu5a/b receptor (1/1,000) and a
monoclonal anti-GFP antibody (1/2,000). The primary bound antibody was
detected using a HRP-conjugated goat anti-rabbit antibody (1/60,000) or
HRP-conjugated rabbit anti-mouse antibody (1/6,000). The immunoreactive
bands were visualized by chemiluminescence.
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ments on adult rat striatal homogenates and double immuno-
labeling on primary cultures of rat striatum neurons were
performed. Using soluble extracts from adult rat striatum,
which had been shown by Western blotting to contain both
-actinin and the mGlu5a/b receptor (Fig. 6A), the anti--acti-
nin antibody could co-immunoprecipitate a band 130 kDa,
which was detected using an anti-mGlu5a/b receptor antibody
(Fig. 6A,upper panel, lane 3). This band did not appearwhen an
irrelevant rabbit IgG was used for immunoprecipitation (Fig.
6A, upper panel, lane 1), showing that the reaction was specific
and that the detected bandmight correspondmainly tomGlu5b
receptor variant, because this is themajor adult form expressed
in striatum (5). Interestingly, when the same blot was reacted
with an antibody against NR1 subunit of the NMDA-type glu-
tamate receptor, a band of 130 kDa corresponding to this
NMDA subunit was detected in the immunoprecipitate with
the anti--actinin antibody (Fig. 6A, lower panel, lane 3), as
expected (18, 19). Also, a similar faint band was observed in the
immunoprecipitate with the anti-mGlu5a/b antibody (Fig. 6A,
lower panel, lane 2), suggesting that NMDA receptor might be
somehow physically associated to the mGlu5a/b receptor in rat
striatum.
The distribution of -actinin and the mGlu5a/b receptor in
primary rat striatal neurons was also analyzed using confocal
microscopy analysis, and a similar punctate distribution and
some degree of co-distribution for both proteins were found
(Fig. 6B). Co-distribution occurred mainly at specific aggre-
gates in dendrites (Fig. 6B, arrows in inset panel). Interestingly,
the single labels for mGlu5a/b or for -actinin give the same
pattern as seen in the double co-staining (i.e. simultaneous
detection of mGlu5 plus -actinin), suggesting that the co-im-
munodetection is indeed specific (data not shown). These
observations are consistent with the concept that-actinin and
mGlu5a/b receptor associate in striatal neurons.
-Actinin-1 Promotes Cell Surface Expression of mGlu5b
Receptor—To gain insight into the physiological consequences
of the -actinin-1/mGlu5b receptor interaction, the effect of
-actinin-1 on the mGlu5b receptor cell surface expression was
studied. To this end we isolated mGlu5b receptors present in
the plasma membrane by cell surface protein biotinylation,
using a membrane impermeant biotin ester, followed by
streptavidin-agarose affinity precipitation of the membrane
proteins. The results showed that the amount of mGlu5b recep-
tor present at the cell surface is increased when mGlu5b recep-
tor and -actinin-1 are co-expressed, compared with the prop-
erties present when mGlu5b receptor is expressed alone (Fig.
7A, Cell Surface, upper panel, lanes 6 versus 5). Quantitation of
FIGURE 5. FRET efficiency of the mGlu5b-GFP
2 and -actinin-YFP pair by
sensitized emission in living cells. HEK-293 cells were transiently trans-
fected with the plasmids encoding the mGlu5b-GFP
2 (donor) and the -acti-
nin-1-YFP constructs (acceptor) using a ratio of donor to acceptor DNA of 1:2.
The -actinin-1-YFP constructs used in the co-transfection were the same
used in Fig. 3. The plasmid encoding the construct GFP2-YFP was transfected
and used as a positive control. Fluorescence readings were performed 48 h
post transfection as described under “Experimental Procedures.” Linear un-
mixing of the emission signals was applied to the data (see “Experimental
Procedures”), and the results are shown as the sensitized emission of the
acceptor when the cells were excited at 400 nm. Data are the mean S.D. of
five to nine independent experiments performed in triplicate. Data of the
different transfection groups were analyzed by one-way analysis of variance
followed by Newman-Keuls post-hoc comparisons. **, p  0.05 or ***, p 
0.001 versus themGlu5b-GFP
2 and YFP co-transfected cells (negative control).
FIGURE 6. In vivo interaction of mGlu5 receptor and -actinin in rat stria-
tum.A, solubilized extracts from rat striatum (see “Experimental Procedures”)
were subjected to immunoprecipitation analysis using nonspecific rabbit IgG
(lane 1), rabbit anti-mGlu5a/b receptor antibody (2 g/ml) (lane 2), and rabbit
anti--actinin (2 g/ml) (lane 3). Extracts (Crude) and/or immunoprecipitates
(IP) were analyzed by SDS-PAGE and immunoblotted using a polyclonal anti-
body againstmGlu5a/b receptor (1/1000), amonoclonal antibody against NR1
(1/1000), and a polyclonal antibody against -actinin (1/1000). The primary
bound antibody against NR1 was detected using a HRP-conjugated rabbit
anti-mouse antibody (1/6000) and the anti-mGlu5a/b receptor antibody was
detected using a HRP-conjugated anti-rabbit IgG TrueBlotTM (1/2000) to
avoid IgG cross-reactivity. The immunoreactive bands were visualized by
chemiluminescence. B, primary cultures of rat striatum neurons (DIV 14–21)
were cultured and processed for immunocytochemistry (see “Experimental
Procedures”) using a polyclonal antibody against mGlu5a/b receptor (1/200)
and amonoclonal anti--actinin antibody (1/100) followedby Texas red-con-
jugated goat anti-rabbit (1/2000) and AlexaFluor488-conjugated goat anti-
mouse IgG (1/1000). Cells were analyzed by double immunofluorescence
with a confocal microscope. Superimposition of images (merge) reveals co-
distribution in yellow (arrow in the inset panel). Scale bar: 10 m.
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the increase of membrane bound/localized mGlu5b receptor
indicated that the levels of surface receptor had risen by up to
4-fold in the -actinin-1 co-transfected cells (Fig. 7B). Under
similar conditions, when the mGlu5b receptor was co-trans-
fected with -actinin-1 mutants lacking the actin binding
domain, i.e. -actinin-1-(358–892)-YFP, -actinin-1-(746–
892)-YFP, and -actinin-1-(816–892)-YFP, there was a reduc-
tion in plasma membrane mGlu5b receptor expression when
compared with cells transfected with the mGlu5b receptor
alone (Fig. 7A, Cell Surface, upper panel, lanes 7–9 versus lane
5). Interestingly, when the streptavidin isolates were reacted
with the anti-GFP antibody to detect -actinin-1 constructs, it
became apparent that -actinin-1 could be observed in the
streptavidin isolates from the cells that were co-transfected
with the mGlu5b receptor (Fig. 7, Cell Surface, middle panel,
lane 6), suggesting that -actinin-1 might be associated with
the cell surface mGlu5b receptor. These results are in agree-
ment with the marked overlap observed in the distribution of
these two proteins found at the plasmamembrane level (Fig. 3).
Because no calnexin could be detected in the streptavidin iso-
lates, it was clear that the biotin ester hadnot penetrated the cell
membrane (Fig. 7, Cell Surface, lower panel). Because -acti-
nin-1 mutants lacking the domain responsible for the interac-
tion with actin (calponin homology domain) inhibit receptor
cell surface expression, these results suggest that the -actinin-
1-mediated-mGlu5b receptor plasma membrane expression
requires the actin cytoskeleton.
Functional Implications of the mGlu5b Receptor--Actinin-1
Interaction—Recently, we have described thatmGlu5b receptor
can signal through the extracellular signal-regulated MAPK
cascade (35). On the other hand, it has been shown that -ac-
tinin isoforms interact with the MEK activator MEKK1 (38) or
the extracellular signal-regulated kinase, ERK (39). To test the
functional consequences of-actinin-1/mGlu5b receptor inter-
action we studied the activation of the MAPK pathway by the
mGlu5b receptor in HEK cells transiently expressing the
mGlu5b receptor in the absence, or presence, of -actinin-1
(receptor densities were controlled by immunoblotting, data
not shown). Treatment with quisqualic acid (100 M) did not
induce ERK1/2 phosphorylation in cells transfected with -ac-
tinin-1 alone. However, in cells transfected with the mGlu5b
receptor alone quisqualic acid did induce a significant ERK1/2
phosphorylation, as expected (35). Interestingly, when cells
were transiently transfected with both -actinin-1 and the
mGlu5b receptor a synergistic potentiation of ERK1/2 phospho-
rylation after receptor activation was observed (Fig. 8).
DISCUSSION
In this study, we have identified an interaction between the
mGlu5b receptor and -actinin-1 and have shown that this
interaction can regulate cell surface expression and function of
the receptor. A yeast two-hybrid screen was initially used to
identify a novel interaction between the heptaspanning mem-
brane mGlu5b receptor and the actin cross-linking protein
-actinin-1. This interaction was subsequently confirmed by
means of pull-down experiments using GST and -actinin-1-
GST fusion constructs, and by co-distribution and co-immu-
noprecipitation experiments in transfected HEK-293 cells.
Moreover, co-distribution of both proteins in rat striatum pri-
mary cultures and the ability of anti--actinin antibodies to
immunoprecipitatemGlu5 receptor from rat striatumhomoge-
nates suggest that the interaction is physiologically relevant.
-Actinin-1 is a rod-shaped molecule composed of two 100-
kDa anti-parallel monomers, linking actin filaments in a paral-
lel way (Fig. 9). In the present work the mGlu5b receptor inter-
acting region of -actinin-1 was mapped within the last 76
amino acids of the molecule. Interestingly, for -actinin-2, one
of the two skeletal muscle isoforms of -actinin that is also
expressed in brain (18, 19), this domain is involved in the inter-
action with the Z repeats of titin in skeletal muscle (40, 41).
Furthermore, the same 76 residues of -actinin-2 have been
FIGURE 7. Cell surface expression of mGlu5 receptor in HEK-293 cells.
A, HEK-293 cells were transiently transfected with -actinin-1-YFP (lane 1),
-actinin-(358–892)-YFP (lane2),-actinin-(746–892)-YFP (lane3),-actinin-
(816–892)-YFP (lane 4), mGlu5b receptor alone (lane 5), mGlu5b receptor plus
-actinin-1-YFP (lane 6), mGlu5b receptor plus -actinin-(358–892)-YFP (lane
7),mGlu5b receptor plus-actinin-(746–892)-YFP (lane 8), ormGlu5b receptor
plus-actinin-(816–892)-YFP (lane 9). Cell surface labelingwas performed as
described under “Experimental Procedures.” Crude extracts and biotinylated
proteins were subsequently analyzed by SDS-PAGE and immunoblotted
using a rabbit anti-mGlu5 receptor antibody (1/1,000), a rabbit anti--actinin
antibody (1/2,000), and a mouse anti-calnexin antibody (1/250). The primary
bound antibody was detected using a HRP-conjugated goat anti-rabbit anti-
body (1/60,000) or HRP-conjugated rabbit anti-mouse antibody (1/6,000).
The immunoreactive bands were visualized by chemiluminescence. B, quantifi-
cation of cell surface receptor. The intensities of the immunoreactive bands on
x-ray film corresponding to crude extracts and biotinylated protein were meas-
ured by densitometric scanning. Cell surface receptor values were normalized
using the total amount of receptor in the crude extract for each sample. The
results are presented asmeans S.E. of three independent experiments.
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shown to interact with ZASP (Z band alternately spliced PDZ-
containing protein), another sarcomere Z disk protein (8, 42,
43). In the central nervous system, this region in the-actinin-4
interacts with the PDZ (PSD-95, Dgl, Z0–1) domain of densin-
180 and with Ca2/calmodulin-dependent protein kinase II
(CaMKII), forming a ternary complex stabilized by multiple
interactions (12, 37, 44). Also, for-actinin-4 the same region is
involved in the interaction with densin-180, a transmembrane
protein that is tightly associated with the postsynaptic density
in central nervous system neurons and that is postulated to
function as a synaptic adhesion molecule (12). The PDZ
domain of densin-180 contributes to its binding to -actinin-4
(12). Furthermore, the C-terminal region of-actinin-2 (amino
acids 819–894), and the highly related proteins-actinin-1 and
-actinin-4 interact with CaMKII (37). Apart from these inter-
actions, the -actinin family members also interact with cell
surface receptors such as the Kv1-type potassium channel (45),
the ATP-gated ion channel P2X7 (46), and the glutamate
NMDA receptor (47). -Actinin binds to the NMDA receptor
NR1 and NR2B subunit C termini at the C0 region, where it
competes with calmodulin, which also binds NMDA receptors
at the same site (48, 49). Displacement of -actinin from the C0
region by calmodulin has been implicated in calcium-depend-
ent inactivation of NMDA receptor-mediated whole cell cur-
rents (50). It has also been postulated that under resting cellular
conditions -actinin is bound to the NMDA receptor. This
interaction predominantly decreases single channel closed
time, resulting in an increased open probability (Popen). When
the intracellular calcium concentration increases during neu-
ronal excitation, calmodulin binds to, and -actinin dissociates
from, the receptor, causing an increase in mean channel closed
time, a decrease in mean channel open time, and an overall
reduction in Popen (51). It has also been suggested that the asso-
ciation of -actinin with NMDA receptors may contribute to
theNR2 subunit-selectivemodulation of this receptor, by local-
izing inactive CAMKII to the NMDA receptor (44, 52). In this
context, it is interesting to note that anNMDA/-actinin inter-
action has been reported in rat striatum (18, 19) where the
mGlu5a/b receptor is also expressed. Furthermore, activation of
mGlu5a/b receptors results in a pronounced potentiation of
NMDA responses in several brain regions (53, 54), including
the striatum (55), suggesting thatmGlu/NMDA receptor inter-
actions are of widespread significance. Indeed, cross-talk
between type I mGlu and NMDA receptors has also been dem-
onstrated in different types of central nervous system neurons,
including cultured cortical neurons (56), cultured striatal
neurons (57), and hippocampal CA3 pyramidal cells (58).
The one or more mechanisms by which activation of
mGlu5a/b receptor modulates NMDA receptor function are
not well understood, and different hypotheses to explain the
enhancement of NMDA currents by type I mGlu receptors
have been proposed. For example, receptor-mediated phos-
phorylation of the NMDA receptor NR2A/B subunits by
protein kinases, such as protein kinase C (56, 58), increases
the open probability of the channel. Interestingly, NMDA
receptor-mediated responses in layer V pyramidal neurons
of the rat prefrontal cortex were facilitated by purinergic P2
receptor activation. The mechanisms underlying this facili-
tation implicated the activation of type I mGlu receptors,
FIGURE 8. Stimulation of ERK1/2 activity by mGlu5b receptor. Serum-
starved HEK cells expressing mGlu5b receptor in the absence or presence of
-actinin were stimulated with quisqualic acid (100 M) for 5 min. The phos-
phorylation of ERK1/2 was determined by immunoblotting (see “Experimen-
tal Procedures”). Bottom, representative ERK assay; top, the intensities of the
immunoreactive bands on x-ray film corresponding to ERK1/2 and phospho
ERK1/2proteinweremeasuredbydensitometric scanning. All values of phos-
phorylated ERK1/2were normalized using ERK1/2 and expressed asmeans
S.E. (in relative densitometric scanning (RDS) obtained in non-treated trans-
fected cells) of three independent experiments.
FIGURE 9. Proposed model of -actinin/mGlu5 receptor interaction. The
upper panel shows a linear structure of -actinin containing the calponin
homology domains (CH), four spectrin-like motifs (SPEC), the EF-hand
domains (EFH), and the receptor binding domain (RBD). The lower panel
shows theproposed-actinin/mGlu5 receptor interactingmodelwhere-ac-
tinin dimers link actin filaments in a parallel way and anchor the receptor to
the plasma membrane.
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namely mGlu1 and mGlu5a/b receptors, via the Gq/phospho-
lipase C/inositol 1,4,5-trisphosphate/Ca2/CAMKII trans-
duction pathway (59).
It is important to note that the -actinin domains mediating
interactions with NMDA and mGlu5a/b receptors are different,
meaning that simultaneous interaction of -actinin with both
receptors could take place. Under this scenario, the close asso-
ciation of NMDA and mGlu5a/b receptors would facilitate the
modulation of NMDA receptor-mediated currents by the
mGlu5 receptor.On the other hand, it is also likely that the actin
cytoskeleton, and -actinin in particular, may have a role in the
regulation of NMDA receptor function by the mGlu5a/b recep-
tor in the rat striatum.
The presence of a complex involving the mGlu5a/b receptor
and -actinin suggests that -actinin may mediate the associa-
tion of the receptor with the actin cytoskeleton. Other studies
have identified filamin A, another actin cross-linking protein
similar to -actinin, as an intracellular binding partner for
other heptaspanning membrane receptors, namely the dopa-
mine D2 and D3 receptors (60, 61), the calcium-sensing recep-
tors (CaRs) (62), the metabotropic glutamate receptor 7 (63),
the -opioid receptor (64), and the calcitonin receptor (65).
Filamin A/D2 receptor interaction is required for the proper
targeting or stabilization of dopamineD2 receptor at the plasma
membrane (61, 66) and may contribute to its cell surface clus-
tering (60). On the other hand, the interaction of CaR with
filamin A prevents the degradation of the receptor, increasing
its total cellular expression and plasmamembrane localization,
thus facilitating CaR signaling to theMAPK pathway (67). Fur-
thermore, silencing the filamin A gene expression inhibits CaR
signaling (68). In the case of the -opioid receptor its interac-
tion with filamin A is required for proper trafficking and regu-
lation of the receptor (64). The calcitonin receptor-filamin A
interaction causes an increase in the recycling of the receptor to
the cell surface and decreased degradation of the receptor, sug-
gesting an important role for filamin in the endocytic sorting
and recycling of the internalized calcitonin receptor (65). In
contrast to the well documented interaction of filamin A with
several heptaspanning membrane receptors, for -actinin only
one previous study has reported an interaction of this actin-
binding protein with a G-protein-coupled receptor, namely the
adenosineA2A receptor (20). Here it was shown that the attach-
ment of the A2A receptor to the actin cytoskeleton through a
direct interaction with -actinin-2 is a pre-requisite for its ago-
nist-induced plasma membrane clustering and -arrestin-me-
diated internalization (20). Although the A2A receptor was the
first G-protein-coupled receptor documented to bind to an
-actinin isoform, namely the -actinin-2, here we show that
mGlu5b receptor also interacts with -actinin-1 and that this
interaction promotes cell surface expression of the receptor.
Interestingly, this -actinin-1-dependent cell surface expres-
sion of the receptor is maintained by the actin cytoskeleton,
becausemutants lacking the calponin homology domain,which
renders them unable to bind actin, do not promote cell surface
expression of the receptor.
-Actinin isoforms also interact with proteins involved in
signal transduction, such as the MEK activator MEKK1 or the
extracellular signal-regulated kinase, ERK, as mentioned previ-
ously (38, 39). Also, mGlu5b receptor can signal through the
extracellular signal-regulated MAPK cascade (35). Taking all
this evidence together, it seems that -actinin has a dual role as
an actin cytoskeleton component and as a scaffolding protein,
anchoring receptors to their target signaling molecules and
thus ensuring a rapid and efficient signal transduction. A simi-
lar hypothesis has been suggested for filamin A, because this
protein interacts withMEKs 1/2, p38 kinases (69), and the Ras-
related GTPases, Rac, RhoA, Cdc42, and RalA (70). Also con-
sistent with this double function as a scaffolding and an adaptor
protein, the interaction of filamin A increases the coupling effi-
ciency of the dopamine D2 receptor with adenylate cyclase (60,
61) and is a prerequisite required for activation of MAPK sig-
naling by the calcium-sensing receptor (67). Here we demon-
strate, as for filaminA, that-actinin-1 promotesmGlu5 recep-
tor signaling through the extracellular signal-regulated MAPK
cascade, suggesting a functional role for the -actinin-1/
mGlu5b receptor interaction in addition to anchoring the
receptor to the actin cytoskeleton.
In summary, a direct interaction between -actinin-1 and
mGlu5b receptor has been identified by using the yeast two-
hybrid system and confirmed by convergent techniques in
transfected HEK-293 cells and in more physiological models
such as cultured neurons or rat striatum. Finally, we describe
that the -actinin-1-dependent cell surface expression of the
receptor depends on the proper -actinin-1 attachment to the
actin cytoskeleton, facilitating the receptor coupling to the sig-
nal transduction machinery.
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